Advanced search
Publication Cover
Annals of Medicine Volume 54, 2022 - Issue 1
Submit an article Journal homepage
2,090
Views
2
CrossRef citations to date
0
Altmetric
Hematology

Outcomes of adolescents and young adults with chronic-phase chronic myeloid leukaemia treated with tyrosine kinase inhibitors

Yuriko Nishiyama-Fujitaa Department of Hematology, Yokohama Municipal Citizen’s Hospital, Yokohama, JapanORCID Iconhttps://orcid.org/0000-0003-3338-0938View further author information
ORCID Icon,
Tomonori Nakazatoa Department of Hematology, Yokohama Municipal Citizen’s Hospital, Yokohama, JapanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-3579-4018View further author information
ORCID Icon,
Noriyoshi Iriyamab Department of Medicine, Division of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, JapanView further author information
,
Michihide Tokuhirac Department of Hematology, Saitama Medical Center, Saitama Medical University, Saitama, JapanView further author information
,
Maho Ishikawad Department of Hemato-Oncology, International Medical Center, Saitama Medical University, Saitama, JapanView further author information
,
Eriko Satoe Department of Hematology, Juntendo University Nerima Hospital, Tokyo, JapanView further author information
,
Tomoiku Takakuf Department of Hematology, Juntendo University School of Medicine, Tokyo, JapanView further author information
,
Keiji Sugimotog Department of Hematology, Juntendo University Urayasu Hospital, Urayasu, JapanView further author information
,
Hiroyuki Fujitah Department of Hematology, Saiseikai Yokohama Nanbu Hospital, Yokohama, JapanView further author information
,
Isao Fujiokaf Department of Hematology, Juntendo University School of Medicine, Tokyo, JapanView further author information
,
Shun Tsuchiyaf Department of Hematology, Juntendo University School of Medicine, Tokyo, JapanView further author information
,
Yuta Kimurac Department of Hematology, Saitama Medical Center, Saitama Medical University, Saitama, JapanView further author information
,
Eisaku Iwanagai Department of Hematology, Kumamoto University Hospital, Kumamoto, JapanView further author information
,
Norio Komatsuf Department of Hematology, Juntendo University School of Medicine, Tokyo, JapanORCID Iconhttps://orcid.org/0000-0003-1880-9126View further author information
ORCID Icon,
Norio Asoud Department of Hemato-Oncology, International Medical Center, Saitama Medical University, Saitama, JapanView further author information
,
Masahiro Kizakic Department of Hematology, Saitama Medical Center, Saitama Medical University, Saitama, JapanView further author information
,
Yoshihiro Hattab Department of Medicine, Division of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, JapanView further author information
&
Tatsuya Kawaguchij Medical Technology, Kumamoto Health Science University, Kumamoto, JapanView further author information
 show all
Pages 1244-1254 | Received 19 Oct 2021, Accepted 18 Apr 2022, Published online: 29 Apr 2022

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Nobuko Hijiya & Michael J Mauro. (2023) Asciminib in the Treatment of Philadelphia Chromosome-Positive Chronic Myeloid Leukemia: Focus on Patient Selection and Outcomes. Cancer Management and Research 15, pages 873-891.
Read now
Sinan Mersin, Fatih Gülük, Emirhan Gülcan & Ahmet Emre Eşkazan. (2023) Current and emerging tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia in young adults. Expert Opinion on Pharmacotherapy 24:15, pages 1703-1713.
Read now

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.